What is the optimal dosing schedule and duration of zoledronic acid in breast cancer patients with bone metastases?   

Is a monthly schedule x 1 year, followed by q3 months, now the the standard of care, as per the recently published OPTIMIZE-2 trial? 



Answer from: Medical Oncologist at Academic Institution